Home › Cases › The Psoriasis That Was Stopped
Erythroderma
The Psoriasis That Was Stopped
6 questions
Question 1 · The Trigger
Correct answer: Erythrodermic psoriasis precipitated by abrupt withdrawal of therapy — a recognised and preventable trigger
Why
Psoriasis, especially after abrupt therapy withdrawal, is the first cause listed.
- It applies to methotrexate, biologics, ciclosporin — and to systemic steroids given for another reason and then stopped, which is the version that catches people out
- Stopping methotrexate before surgery is often appropriate, but it needs a plan for the psoriasis rather than simply an omission
- A drug reaction is possible but does not explain the timing against a known and specific trigger
- Cutaneous lymphoma — Sézary — would be suggested by lymphadenopathy, and would not be precipitated by stopping methotrexate
Key point
Stopping psoriasis treatment abruptly can cause erythroderma. Including steroids given for something else.
Question 2 · Recognising the Cause
Correct answer: Nail changes — pitting, onycholysis — and a known history with typical distribution before the erythroderma
Why
Nail changes are the giveaway. The pathway lists psoriasis/eczema history and nails under hunting the cause.
- Once more than 90% of the skin is inflamed, the morphology that would normally identify the disease is lost — everything looks the same. The nails are preserved evidence
- Pitting, onycholysis, subungual hyperkeratosis and oil-drop change all point to psoriasis
- Scale occurs in eczema, psoriasis, drug reactions and lymphoma and discriminates nothing
- The colour of erythema is not a useful discriminator
Key point
Look at the nails. Once everything is red, the nails are the last surviving clue.
Question 3 · Treatment
Correct answer: Restarting or starting systemic therapy for psoriasis is dermatology-led definitive care — the decision and agent are theirs
Why
Dermatology-led definitive care: restart or start systemic therapy for psoriasis. The principle is right; the decision belongs to dermatology.
- In erythrodermic psoriasis the choice of agent matters — ciclosporin or infliximab are often preferred for rapid control, and methotrexate is slower
- Restarting unilaterally at the previous dose in a systemically unwell patient with possible infection and deranged renal function is not safe
- Stopping the therapy caused this; the therapy did not — that inversion would leave her untreated
- Any erythroderma needs a same-day dermatology discussion
Key point
Restarting is right; choosing the drug is dermatology's. Erythrodermic psoriasis often needs faster agents.
Question 4 · The Sepsis Question
Correct answer: Culture first, then treat proven infection — but a low threshold for flucloxacillin if staphylococcal sepsis is suspected clinically
Why
Secondary staphylococcal sepsis — culture, treat proven infection, with flucloxacillin 2g QDS IV if suspected.
- The tension is real: erythroderma itself causes fever and a raised CRP through massive cutaneous inflammation, so the markers are hard to interpret
- But the skin barrier is gone and staphylococcal sepsis is a named killer in this condition, so the threshold for treating clinically suspected infection is low
- Culture first where possible — blood cultures and skin swabs
- Prophylactic antibiotics are not the approach, as in SJS/TEN — but that is different from being slow to treat suspected sepsis
Key point
Fever alone is not sepsis here — but the barrier is gone. Culture, then a low threshold to treat.
Question 5 · Fluids
Correct answer: Continue fluids guided by balance and urine output — do not chase the oedema with diuretics
Why
Losses are large, albumin often falls — do not chase oedema with diuretics. The pathway states it in the drug notes.
- The oedema is from low oncotic pressure and capillary leak, not fluid overload. She is intravascularly depleted despite looking wet, and diuresing her causes hypotension and renal failure
- Guide fluids by balance and urine output
- Albumin infusion does not correct the underlying protein loss and is not standard here
- The same trap appears in other conditions where the patient looks overloaded and is actually dry
Key point
Oedematous and intravascularly dry. Diuretics will drop her pressure and her kidneys.
Question 6 · Preventing It
Correct answer: Stopping psoriasis therapy needs a plan and dermatology input, not simply an omission on a pre-operative checklist
Why
Abrupt therapy withdrawal is a recognised trigger, so it is a foreseeable and preventable event.
- Stopping immunosuppression before surgery is often clinically appropriate — the failure is stopping it without a plan for what happens to the psoriasis, and without dermatology knowing
- The parallel is exact with the Parkinson's pathway: stopping a time-critical medication for a procedure needs a plan made at the time the decision is made, not discovered afterwards
- Blanket instructions in either direction — never stop, or always stop — are both wrong
- Document an alert so the same omission does not recur at her next operation
Key point
Stopping it may be right; stopping it without a plan is not. Same lesson as NBM Parkinson's.
Case complete
Practice on this page does not update your app progress. Open the browser app if you want its learning tools and progress record.